Stock ownership · SEC 13F · Q4 2025
ZEVRA THERAPEUTICS INC COM NEW
Who owns ZEVRA THERAPEUTICS INC COM NEW (CUSIP 488445206)? A look at the institutions behind it, how tightly they hold it, and the latest quarter's moves.
- $133K
- Reported value
- 1
- Institutions
- 100%
- Top-5 share
The verdict
As of Q4 2025, 1 institutions report $133K in ZEVRA THERAPEUTICS INC COM NEW positions, ownership that is dominated by its top few institutional owners.
- 1
- institutions hold it
- $133K
- reported 13F value
- 100%
- held by top 5
Based on long positions reported to the SEC as of Q4 2025; 13F omits shorts, options and non-US holdings.
How 13F ownership is computed · All tracked stocks · Concentration rankings
SEC Form 13F-HR ownership desk
CUSIP 488445206 · Q4 2025 $0M reported
VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-QUIET · BOOK-MID
- VALUE-TRACE $0.1M
- HOLDERS-FOCUS 1 filers
- CONC-DOM 100% top-5
- PHOTO-UNK No peer
- ACTIVITY-QUIET 0 new
- BOOK-MID 6Q history
Read with: Ownership concentration guide - ZEVRA THERAPEUTICS INC COM NEW's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.
Institutional ownership over time
The number of institutions reporting a ZEVRA THERAPEUTICS INC COM NEW position has held steady from 1 to 1 over the last 6 quarters of 13F filings.
Top Institutional Holders
| # | Institution | Shares | Value | Share of reported |
|---|---|---|---|---|
| 1 | DGS Capital Management, LLC | 14,810 | $133K | 100.0% |
Investment Discretion
SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among ZEVRA THERAPEUTICS INC COM NEW's reported holders for Q4 2025, by reported value:
Frequently Asked Questions
How many institutions hold ZEVRA THERAPEUTICS INC COM NEW?▼
What is the total institutional value of ZEVRA THERAPEUTICS INC COM NEW?▼
How concentrated is ownership of ZEVRA THERAPEUTICS INC COM NEW?▼
Who is the largest institutional holder of ZEVRA THERAPEUTICS INC COM NEW?▼
Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.
PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-09-26.